Cereno Scientific Pipeline
| Drug | Indication | Phase |
|---|
| CS1 | Pulmonary Arterial Hypertension (PAH) | Phase II |
| CS014 | Idiopathic Pulmonary Fibrosis (IPF) / Pulmonary Hypertension-ILD (PH-ILD) | Phase I |
| CS585 | Cardiovascular Disease (Thrombosis prevention, Pulmonary Hypertension) | Preclinical |